Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04740424
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2021-01-28
Brief Title:
FS222 First in Human Study in Patients With Advanced Malignancies
Sponsor:
invoX Pharma Limited
Organization:
invoX Pharma Limited
Organization Data
Organization:
invoX Pharma Limited
Class:
INDUSTRY
Study ID:
FS222-19101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
invoX Pharma Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None